ENTG

Business Context and Reporting Period

Company: Entegris, Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended November 26, 2005 (First Quarter of Fiscal 2006).
Context: The Company completed a merger with Mykrolis Corporation on August 6, 2005, accounted for as a purchase. This is the first quarter of operations post-merger. The Company also announced a change in its fiscal year end from the last Saturday of August to December 31, effective December 13, 2005. Entegris provides materials integrity management products to the semiconductor and data storage industries.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 65% year-over-year, primarily driven by the inclusion of Mykrolis sales ($64.7 million). Sequentially, sales were 46% higher than the prior quarter.
• Margin Compression: Gross margin declined to 32.5% from 42.2%. This was significantly impacted by a $17.8 million charge for the write-up of inventory acquired in the Mykrolis merger and $2.5 million in restructuring costs.
• Expense Increase: Selling, General, and Administrative (SG&A) expenses surged 136% to $56.5 million due to Mykrolis integration costs ($8.1 million), higher amortization of intangibles ($3.6 million), and increased stock-based compensation ($7.4 million).
• Profitability: The Company reported a net loss of $16.1 million compared to net income of $5.7 million in the prior year. This includes a $10.1 million loss from continuing operations and a $5.9 million loss from discontinued operations.
• Discontinued Operations: The Company classified gas delivery, life science, and tape and reel product lines as discontinued operations, recording a $5.1 million impairment loss on long-lived assets.

Guidance, Outlook, and Risks

• Integration Costs: Management expects to incur total integration expenses of approximately $30 million related to the Mykrolis merger, with $22 million already recorded. Annualized cost savings of $20 million are expected to be fully realized by mid-2006.
• Divestitures: The life science and tape and reel businesses were sold in December 2005. The gas delivery business is expected to be sold in Q1 2006 for approximately $15 million.
• Plant Closure: The Company announced the closure of its Bad Rappenau, Germany manufacturing plant in 2006, expecting $3.5 million in severance/closure costs and up to $3.0 million in asset impairment charges.
• Capital Expenditures: Future capital expenditures are projected at $40 million through calendar 2006.
• Internal Controls: The Company identified a material weakness in internal controls regarding purchase accounting for compensation matters. Remediation efforts were initiated, but controls were deemed not effective as of November 26, 2005.
• Liquidity: The Company maintains a $10 million unsecured revolving credit facility and international lines of credit totaling $15.2 million. Management believes current cash and credit facilities are sufficient for the next 12 months.

Investor Verification Checklist

• Merger Accounting: Verify the final purchase price allocation for the Mykrolis acquisition, specifically regarding the $17.8 million inventory write-up and goodwill adjustments.
• Discontinued Operations: Confirm the closing dates and final proceeds for the divestiture of the gas delivery, life science, and tape and reel businesses.
• Integration Synergies: Monitor the realization of the projected $20 million in annualized cost savings and the timeline for SG&A expense reduction.
• Internal Control Remediation: Review subsequent filings for confirmation that the material weakness in internal controls has been remediated and tested.
• Germany Plant Closure: Track the actual costs incurred for the Bad Rappenau plant closure against the estimated $6.5 million total impact.